AI Drug Discovery Startups: Berg Health Focuses AI on Prostrate Cancer and Parkinsons

The high growth AI-drug discovery market has attracted several players. However, the high cost of drug development, and the slow regulatory process associated with drug release has also led to several consolidations. One such story is that of Berg Health.

Featured Videos

AI Investor Forum: Gus Tai on AI in Healthcare (Part 8)

Sramana Mitra: What is going on in the thought process of the venture capital community vis-a-vis healthcare drug discovery and general AI in the healthcare and life sciences area? When the lean startup movement came about, SaaS was the dominant field in which VCs were investing for maybe even 15 years, the venture capital industry kind of settled into this model that you bootstrapped to some level of validation and then start raising money.

2025 Resolution: Bootstrap a Startup with a Paycheck, Zero-In on an Idea

Are you trying to find a startup idea to build your entrepreneur dream on?

Well, let’s make it happen in 2025!

The best startup ideas stem from personal experiences or industry frustrations.

If you are looking for viable ideas, try this method.

>>>

Video FAQs

AI Investor Forum: Gus Tai on AI in Healthcare (Part 7)

Sramana Mitra: So now, let’s switch a little bit to surgery. Now comes the domain of robotic surgery, which is again, a very, very important and very promising area of AI application. It could really change human’s level of access to healthcare in a very big way. However, from a startup point of view, building surgical robots is an expensive game.

AI Investor Forum: Gus Tai on AI in Healthcare (Part 6)

Sramana Mitra: Some of you here would remember, Gus would definitely remember that many years ago, I came up with a formula for the future of the web. It was called Web 3.0 = (4C + P + VS).

Colors: Village Square I

I’m publishing this series on LinkedIn called Colors to explore a topic that I care deeply about: the Renaissance Mind. I am just as passionate about entrepreneurship, technology, and business, as I am about art and culture. In this series, I will typically publish a piece of art – one of my paintings – and I request you to spend a minute or two deeply meditating on it. I urge you to watch your feelings, thoughts, reactions to the piece, and write what comes to you, what thoughts it triggers, in the dialog area. Let us see what stimulation this interaction yields. For today – Village Square I

Village Square I | Sramana Mitra, 2022 | Watercolor, Ink | 9  x 12, On Paper

AI Investor Forum: Gus Tai on AI in Healthcare (Part 5)

Sramana Mitra: So, Gus, could you also discuss Joanna Strober’s company that you have invested in and have been tracking for a while? I think it’s a good case study to discuss in this context.

Gus Tai: Absolutely. The company is called Midi Health, and I was a seed investor with Midi. That company is a good illustration of how entrepreneurs, regardless of how they want to think about raising money, can approach industries. There was a latent need and a discontinuity in being able to serve that latent need.

Colors: Heavy Sky III

I’m publishing this series on LinkedIn called Colors to explore a topic that I care deeply about: the Renaissance Mind. I am just as passionate about entrepreneurship, technology, and business, as I am about art and culture. In this series, I will typically publish a piece of art – one of my paintings – and I request you to spend a minute or two deeply meditating on it. I urge you to watch your feelings, thoughts, reactions to the piece, and write what comes to you, what thoughts it triggers, in the dialog area. Let us see what stimulation this interaction yields. For today – Heavy Sky III

Heavy Sky III | Sramana Mitra, 2022 | Watercolor, Ink | 9  x 12, On Paper